Alice Mohr

Statistics

Publications

Citations

896

H-Index

Active since

2002

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Alice Mohr is an author at Roswell Park Comprehensive Cancer Center specializing in hematologic malignancy therapy, medicine, and hematologic oncology.

Publications per year

2002–2021

Publications

Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study

Asher Chanan‐Khan, Kena C. Miller, Laurie Musial et al. · Journal of Clinical Oncology · 2006 · 409 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Rituximab in Combination With Fludarabine Chemotherapy in Low-Grade or Follicular Lymphoma

M. S. Czuczman, Alexandra Koryzna, Alice Mohr et al. · Journal of Clinical Oncology · 2005 · 146 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)

Asher Chanan‐Khan, Kena C. Miller, Kenichi Takeshita et al. · Blood · 2005 · 105 citations

Medicine, Oncology, Pharmacotherapy +12

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies

Paola Ghione, Juan J. Gu, Kristopher Attwood et al. · Blood · 2021 · 105 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma

Myron S. Czuczman, Alexandra Fallon, Alice Mohr et al. · Seminars in Oncology · 2002 · 97 citations

Medicine, Oncology, Pharmacotherapy +9

1–5 of 7